BR9607348A - Compostos biciclicos composições farmacéuticas e processos para o tratamento de artrite asma inflamações crescimento tumoral hipermotilidade gastrointestinal doença de huntigton neurite neuralgia hemicrania hipertens o incotinéncia urinária urticária sintomas de sindrome de carcinóide gripe e resfriado - Google Patents

Compostos biciclicos composições farmacéuticas e processos para o tratamento de artrite asma inflamações crescimento tumoral hipermotilidade gastrointestinal doença de huntigton neurite neuralgia hemicrania hipertens o incotinéncia urinária urticária sintomas de sindrome de carcinóide gripe e resfriado

Info

Publication number
BR9607348A
BR9607348A BR9607348A BR9607348A BR9607348A BR 9607348 A BR9607348 A BR 9607348A BR 9607348 A BR9607348 A BR 9607348A BR 9607348 A BR9607348 A BR 9607348A BR 9607348 A BR9607348 A BR 9607348A
Authority
BR
Brazil
Prior art keywords
incotinence
huntigton
hemicrania
inflammations
neuritis
Prior art date
Application number
BR9607348A
Other languages
English (en)
Inventor
Federico Arcamone
Carlo Alberto Maggi
Laura Quartara
Danilo Giannotti
Original Assignee
Menarini Farma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11351134&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9607348(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Farma Ind filed Critical Menarini Farma Ind
Publication of BR9607348A publication Critical patent/BR9607348A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR9607348A 1995-03-13 1996-03-11 Compostos biciclicos composições farmacéuticas e processos para o tratamento de artrite asma inflamações crescimento tumoral hipermotilidade gastrointestinal doença de huntigton neurite neuralgia hemicrania hipertens o incotinéncia urinária urticária sintomas de sindrome de carcinóide gripe e resfriado BR9607348A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95FI000044A IT1277835B1 (it) 1995-03-13 1995-03-13 Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
PCT/EP1996/001028 WO1996028467A1 (en) 1995-03-13 1996-03-11 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition

Publications (1)

Publication Number Publication Date
BR9607348A true BR9607348A (pt) 1997-12-30

Family

ID=11351134

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607348A BR9607348A (pt) 1995-03-13 1996-03-11 Compostos biciclicos composições farmacéuticas e processos para o tratamento de artrite asma inflamações crescimento tumoral hipermotilidade gastrointestinal doença de huntigton neurite neuralgia hemicrania hipertens o incotinéncia urinária urticária sintomas de sindrome de carcinóide gripe e resfriado

Country Status (33)

Country Link
US (1) US6150325A (pt)
EP (1) EP0815126B1 (pt)
JP (1) JP4618821B2 (pt)
KR (1) KR100405009B1 (pt)
CN (1) CN1189477C (pt)
AR (1) AR004476A1 (pt)
AT (1) ATE198481T1 (pt)
AU (1) AU696528B2 (pt)
BG (1) BG63208B1 (pt)
BR (1) BR9607348A (pt)
CZ (1) CZ287372B6 (pt)
DE (1) DE69611438T2 (pt)
DK (1) DK0815126T3 (pt)
EA (1) EA000697B1 (pt)
EE (1) EE03618B1 (pt)
ES (1) ES2155187T3 (pt)
GE (1) GEP20002271B (pt)
GR (1) GR3035676T3 (pt)
HR (1) HRP960117B1 (pt)
HU (1) HU222051B1 (pt)
IL (1) IL117395A (pt)
IT (1) IT1277835B1 (pt)
MX (1) MX9706927A (pt)
NO (1) NO319290B1 (pt)
NZ (1) NZ303982A (pt)
PL (1) PL184147B1 (pt)
PT (1) PT815126E (pt)
RO (1) RO118297B1 (pt)
SK (1) SK281899B6 (pt)
TW (1) TW565572B (pt)
UA (1) UA48962C2 (pt)
WO (1) WO1996028467A1 (pt)
ZA (1) ZA961983B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017705A (en) * 1995-03-14 2000-01-25 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof
IT1291776B1 (it) * 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1304888B1 (it) * 1998-08-05 2001-04-05 Menarini Ricerche Spa Composti monociclici ad azione nk-2 antagonista e formulazioni che licontengono
NZ523310A (en) * 2000-06-12 2005-07-29 Univ Rochester Tachykinin receptor antagonist to block receptors NK1, NK2, and NK3 and treat symptoms of hormonal variation
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist
ITFI20020239A1 (it) 2002-12-06 2004-06-07 Menarini Ricerche Spa Processo per la preparazione di composti peptidici biciclici.
ITFI20040221A1 (it) * 2004-10-27 2005-01-27 Guidotti & C Spa Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262902B (it) * 1992-04-15 1996-07-22 Menarini Farma Ind Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.

Also Published As

Publication number Publication date
ITFI950044A1 (it) 1996-09-13
PT815126E (pt) 2001-06-29
DE69611438D1 (de) 2001-02-08
IT1277835B1 (it) 1997-11-12
JPH11501643A (ja) 1999-02-09
KR100405009B1 (ko) 2004-05-20
BG101849A (en) 1998-04-30
CN1189477C (zh) 2005-02-16
DE69611438T2 (de) 2001-06-13
TW565572B (en) 2003-12-11
HUP9801835A2 (hu) 1999-01-28
GR3035676T3 (en) 2001-06-29
ITFI950044A0 (it) 1995-03-13
EE03618B1 (et) 2002-02-15
NO319290B1 (no) 2005-07-11
CN1183786A (zh) 1998-06-03
ZA961983B (en) 1997-09-29
ATE198481T1 (de) 2001-01-15
UA48962C2 (uk) 2002-09-16
MX9706927A (es) 1997-11-29
PL184147B1 (pl) 2002-09-30
GEP20002271B (en) 2000-10-25
DK0815126T3 (da) 2001-05-07
EP0815126B1 (en) 2001-01-03
AU5105996A (en) 1996-10-02
AR004476A1 (es) 1998-12-16
PL322105A1 (en) 1998-01-05
EE9700230A (et) 1998-04-15
JP4618821B2 (ja) 2011-01-26
NO974057D0 (no) 1997-09-03
WO1996028467A1 (en) 1996-09-19
NZ303982A (en) 1998-04-27
CZ287372B6 (en) 2000-11-15
NO974057L (no) 1997-11-07
US6150325A (en) 2000-11-21
EA000697B1 (ru) 2000-02-28
HU222051B1 (hu) 2003-04-28
RO118297B1 (ro) 2003-04-30
AU696528B2 (en) 1998-09-10
KR19980703011A (ko) 1998-09-05
ES2155187T3 (es) 2001-05-01
BG63208B1 (bg) 2001-06-29
IL117395A (en) 1999-12-31
EP0815126A1 (en) 1998-01-07
HRP960117B1 (en) 2001-06-30
CZ286297A3 (cs) 1998-02-18
HUP9801835A3 (en) 2000-05-29
HRP960117A2 (en) 1997-08-31
IL117395A0 (en) 1996-07-23
EA199700223A1 (ru) 1998-04-30
SK121297A3 (en) 1998-02-04
SK281899B6 (sk) 2001-09-11

Similar Documents

Publication Publication Date Title
NL300243I1 (nl) Proteïne formuleringen.
PT1133285E (pt) Processo para a producao de particulas com uma regiao amorfa e/ou cristalina metastavel convertida num estado cristalino
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
BR9711805A (pt) Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos
IT1284108B1 (it) Presidio chirurgico per il trattamento dell'enfisema polmonare
SG163576A1 (en) 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
BR9607348A (pt) Compostos biciclicos composições farmacéuticas e processos para o tratamento de artrite asma inflamações crescimento tumoral hipermotilidade gastrointestinal doença de huntigton neurite neuralgia hemicrania hipertens o incotinéncia urinária urticária sintomas de sindrome de carcinóide gripe e resfriado
BR0111892A (pt) Bis-arilsulfonas
EG23150A (en) Process for the purification of pharmacologically active proteins through cathionic enhance chromatography
HUP0101818A1 (hu) N-(3-etinil-fenil)-6,7-bisz(2-metoxietoxi)-4-kinazolinamin-mezilát anhidrát és monohidrát és a vegyületet tartalmazó gyógyászati készítmények
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
CA2396111A1 (en) Substances for use in treating psoriasis
NO20001869L (no) FremgangsmÕte for behandling av Alzheimers sykdom
BR9915904A (pt) Composto, processo de preparação do mesmo, composição farmacêutica e métodos de tratamento de distúrbios
BR9812062A (pt) Composto, uso deste, processo para prepará-lo, enanciÈmero único purificado, composição farmacêutica, e, processos para tratamento de bronquite crÈnica ou de doença pulmonar obstrutiva crÈnica em um indivìduo humano ou animal, e para tratamento de asma em um indivìduo humano ou animal
PT964860E (pt) Atropisomeros de 3-heteroaril-4(3h)-quinazolinonas para o tratamento de condicoes neurogenerativas e relacionadas com trauma do sistema nervoso central
FR2833596B1 (fr) Procede de preparation de derives d'echinocandine
CA2257136A1 (en) Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
MA26252A1 (fr) Usine flottante de traitement d'hydrocarbures.
WO2002058680A3 (en) Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders
NO20034269D0 (no) Anvendelse av forbindelser med den biologiske aktivitet til vaskoaktivt intestinalt peptid for behandlingen av kronisk obstruktiv pulmonalsykdom
BR9811651A (pt) Composto, uso do mesmo, processo para prepará-lo, enanciÈmero único purificado, composição farmacêutica, e, processos para o tratamento de bronquite crÈnica ou doença pulmonar obstrutiva crÈnica em um indivìduo humano ou animal, e para tratamento de asma em um indivìduo humano ou animal
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
WO2001090139A3 (en) A ligand for enhancing oral and cns delivery of biological agents

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/03/2006, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061551/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO0132347-71.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. , ANGELINE RICERCHE S.PA SOCIETA CONSORTILE, ARDOZ PHARMA HOLDING IB.V, ASTRA AKTIEBOLAG, ASTRAZENECA AB, ASTRAZENECA UK LIMITED.